Survival trends in the management of carcinoid heart disease among patients with neuroendocrine neoplasms
{{output}}
Background: Nearly 20% of patients with neuroendocrine tumors (NET) develop carcinoid syndrome (CS), and 20-25% of those with CS develop carcinoid heart disease (CHD). Contemporary risk factors for CHD and prognostic variables in... ...
